MS Validated Antibodies

MS Validated Antibodies (MSVA) is a specialized biotechnology company focused on providing high-quality monoclonal antibodies validated through a rigorous mass spectrometry-based approach. The company addresses the widespread issue of antibody non-specificity by using a unique validation pipeline that involves screening antibodies against thousands of proteins to ensure absolute target specificity, particularly for immunohistochemistry (IHC) applications. Their portfolio includes highly characterized antibodies for clinical diagnostics and research in oncology, pathology, and immunology. By combining traditional validation methods with mass spectrometry, MSVA provides researchers and clinicians with tools that offer superior reliability and reproducibility in protein detection.